The diagnosis of endogenous hyperinsulinemia relies on both the clinical presentation and a specific biochemical profile that demonstrates detectable serum insulin, detectable C-peptide with suppressed ketones, and suppressed free fatty acids in the setting of low plasma glucose [8]. This evidence concerns the gene INS and hyperinsulinism.